Skip to content

Extreme Large Core Infarct Stroke within 24 Hour Time Window: A Multi-center, Prospective, Chinese Cohort of Endovascular Thrombectomy in Acute Stroke

Extreme Large Core Infarct Stroke within 24 Hour Time Window: A Multi-center, Prospective, Chinese Cohort of Endovascular Thrombectomy in Acute Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088952
Enrollment
Unknown
Registered
2024-08-29
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Sponsors

The Second Affiliated Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or over; 2. The time of arrival at the hospital is not more than 24 hours from the onset of stroke or the last normal time; 3. Clinical diagnosis of AIS due to anterior/posterior circulation large vessel occlusion on DSA/CTA/MRA; 4. Alberta Stroke Program Early CT Score (ASPECTS) = 3; 6. Informed consent obtained from patients or their legal representatives. .

Exclusion criteria

Exclusion criteria: 1.Confirmed intracranial hemorrhage through computed tomography (CT) or magnetic resonance imaging (MRI); 2.Pre-stroke modified Rankin Scale (mRS) score >= 2; 3.Pregnancy or breastfeeding women; 4.Genetic or acquired bleeding diathesis, deficiency of anticoagulant factors, or use of anticoagulant medication with an International Normalized Ratio (INR) > 3; 5.Presence of intracranial tumors with mass effect on imaging (excluding small meningiomas); 6.Any end-stage disease with expected survival less than 6 months; 7.Anticipated inability to complete follow-up; 8.Brain herniation causing midline shift; 9.Presence of severe complications that may affect patient prognosis and follow-up (cancer, severe heart failure, renal failure); 10. Suspected septic embolism or bacterial endocarditis; 11. Participating in other clinical trials;

Design outcomes

Primary

MeasureTime frame
The rate of 90-day modified Rankin scale (mRS) score 0-2(%);The rate of symptomatic intracerebral hemorrhage (SICH) at 48-hour and death at 90-day;

Secondary

MeasureTime frame
The rate of 90-day modified Rankin scale (mRS) score 0-3(%);The rate of 90-day modified Rankin scale (mRS) score 0-1(%);Shift in the distribution of mRS scores at 90 days;EQ-5D score at 90 days;The rate of any type of intracranial hemorrhage at 48-hour;The rate of death at 7-day;

Countries

China

Contacts

Public ContactZi Wenjie

The Second Affiliated Hospital of the Army Medical University

ziwenjie1981@163.com+86 185 2303 3816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026